Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  NuPathe Inc    PATH

No quotes available
-- USD   0.00%
2015DJDrug Maker Mylan Sues Law Firm Kirkland & Ellis
2014DJU.S. HOT STOCKS : Hot Stocks to Watch
2014 NUPATHE INC : Endo Merger Agreement with NuPathe Terminated
 SummaryQuotesNewsCalendarCompanyFinancials 
Company
NuPathe Inc. is a biopharmaceutical company focused on the development and commercialization of branded therapeutics for diseases of the central nervous system, including neurological and psychiatric disorders.Its primary product, Zecuity (sumatriptan iontophoretic transdermal) for the acute... 
Sector
Pharmaceuticals
Calendar
08/09Earnings Release
More about the company
Latest news on NUPATHE INC
2015DJDrug Maker Mylan Sues Law Firm Kirkland & Ellis
2014DJU.S. HOT STOCKS : Hot Stocks to Watch
2014 NUPATHE INC : Endo Merger Agreement with NuPathe Terminated
2014 NuPathe Terminates Agreement With Endo and Enters Into Agreement to Be Acquir..
2014 NUPATHE INC : NuPathe Inc. Stockholders Encouraged to Contact Securities Law Fir..
2013 NUPATHE INC : Program Participations and Positive Stock Movements - Research Rep..
2013 NUPATHE INC : NUPATHE INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investi..
2013 NUPATHE INC : INVESTOR ALERT Levi & Korsinsky, LLP Announces Investigation of NU..
2013 NUPATHE INC : Harwood Feffer LLP Announces Investigation of NuPathe, Inc.
2013 NUPATHE INC : PATH SHAREHOLDER ALERT: The Law Firm of Wohl & Fruchter is Investi..
More news
Sector news : Pharmaceuticals - NEC
01:12a OTSUKA : Determination of Final Terms of Share Remuneration-type Stock Options (..
01:06a PFIZER : Prices $5.0 Billion Debt Offering
12:54a VALEANT PHARMACEUTICALS INTL : to report first-quarter results on June 7
12:01a VALEANT PHARMACEUTICALS INTL : To Hold Conference Call On June 7, 2016
05/31 MYLAN : Announces Pricing of Senior Notes
More sector news : Pharmaceuticals - NEC
Advertisement
Income Statement Evolution
More Financials